Gluten Intolerance Treatment Market
Number of pages: 100 | Report Format: PDF | Published date: May 11, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 659.70 million |
|
Revenue Forecast in 2031 |
US$ 1,983.35 million |
|
CAGR |
13.01% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Drug Type, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global gluten intolerance treatment market was valued at US$ 659.70 million in 2022 and is expected to register a revenue CAGR of 13.01% to reach US$ 1,983.35 million by 2031.
Gluten Intolerance Treatment Market Fundamentals
Gluten is a protein naturally found in wheat, barley, rye, and other cereals. It may be found in typical foods and beverages, including pasta, cereal, and beer. Gluten can also be found in vitamins, cosmetics, and some medicines. Gluten intolerance, also known as gluten sensitivity, non-celiac gluten sensitivity, or non-celiac wheat sensitivity, is a condition in which your body reacts negatively to gluten. Gluten intolerance can create digestive issues but fails to permanently damage the stomach, intestine, or other organs.
The research study on the gluten intolerance treatment market overview thoroughly analyzes the market and the aspects that either help or hinder the market's growth, such as its drivers, challenges, and opportunities. The research also discusses the list of businesses that operate in this market and their efforts to establish themselves as significant players through expansion plans and innovative ideas. It also emphasizes current events that support the market's revenue expansion.
This report is an important tool for the industry stakeholders to gather all the information about the market, customers, and competition. The report also provides the readers with valuable insights on the segmentation, regions, market size & forecast, revenue CAGRs, and other valuable data to help make informed strategic decisions. The study compiles information gathered from industry participants and specialists across the industry value chain. The report also taps into the qualitative and quantitative assessments by industry analysts. Our reports use different methods for estimating the market size and forecast, including secondary research, surveys and interviews, and statistical modeling. With these steps, our reports provide the most accurate market data. These datasets will cumulatively provide an in-depth gluten intolerance treatment market forecast to the industry stakeholders.
[1254]
Gluten Intolerance Treatment Market Dynamics
The prevalence of celiac disease and gluten intolerance treatment has been on the rise, leading to increased demand for gluten-free products. This is due to factors such as improved testing methods, increased awareness of the condition, and changes in diagnostic criteria. According to the “75 Celiac Disease & Gluten-Free Statistics & Facts (2023)” article, approximately 6% of the U.S. population suffer from gluten intolerance. More people are becoming aware of the benefits of a gluten-free diet, not only for those with celiac disease or gluten intolerance treatment but also those with other health conditions or looking to improve their overall health. This has led to increased demand for gluten-free products in the market. The availability of gluten-free products has increased significantly in recent years, with many companies expanding their product lines to cater to the growing demand. This includes everything from gluten-free bread and pasta to snacks, beverages, and cosmetics. With the increasing demand for gluten-free products, there has been a rise in innovation in the development of new gluten-free products, including the use of alternative flour and grains. Gluten-free products are no longer limited to specialty health food stores but are now widely available in mainstream supermarkets and online retailers, making them more accessible to consumers.
As more people become aware of the health benefits of a gluten-free diet, there is a growing demand for gluten-free products. This presents an opportunity for companies to expand their product lines and cater to this growing market. There is an opportunity for companies to develop innovative products that meet the needs and preferences of consumers with gluten intolerance treatment, such as gluten-free convenience foods and snacks. The gluten intolerance treatment market is not limited to developed countries but is also growing in emerging markets, with increasing awareness of celiac disease and gluten intolerance treatment. This presents an opportunity for companies to expand their reach and tap into new markets.
Gluten-free products can be more expensive than their gluten-containing counterparts, which can be a barrier for some consumers. Companies may need to find ways to reduce costs without compromising on quality or taste. There is still a lack of awareness and understanding about celiac disease and gluten intolerance treatment, making it challenging for companies to educate consumers and promote their gluten-free products. Formulating gluten-free products can be challenging, as gluten plays a key role in the structure and texture of many foods. Companies must find ways to replicate the taste and texture of gluten-containing products without using gluten. There is a risk of cross-contamination during the production of gluten-free products, which can be a challenge for companies to manage. Companies must take measures to ensure their products are free from gluten contamination.
Gluten Intolerance Treatment Market Ecosystem
Gluten Intolerance Treatment Market, by Type
Gluten Intolerance Treatment Market, by Drug Type
Gluten Intolerance Treatment Market by Type
[258]
Celiac disease registered for prominent revenue shares in the global gluten intolerance treatment market in 2022, majorly attributed to a large patient pool. Celiac disease is a significant contributor to the global gluten intolerance treatment market, as it is a common autoimmune disorder triggered by ingesting gluten. According to the article by “VeryWell Health” in 2022, the incidence of celiac disease in person-years. It was discovered that celiac disease was diagnosed in 17.4 out of every 100,000 women vs. 7.8 out of every 100,000 males. The incidence rate among children was 21.3 per 100,000 youngsters, compared to 12.9 per 100,000 adults. Thus, leading to an increase in demand for gluten intolerance treatment and gluten-free products.
Furthermore, the availability of gluten-free products has also increased, with many companies expanding their product lines to cater to the growing demand. This has led to a broader range of gluten-free products for consumers with celiac disease. In addition, growing awareness of celiac disease and gluten intolerance treatment also contributes to the market's growth. As more people become aware of the condition and its symptoms, there is a growing demand for gluten-free products.
Segmentation of the market refers to the division of the industry into subgroups based on factors such as type, drug type, etc. Market segmentation data helps businesses to understand the preferences and unique needs of different customer groups and develop targeted sales strategies. This information also helps in identifying potential gluten intolerance treatment market growth opportunities.
Gluten Intolerance Treatment Market by Region
Based on region, the global gluten intolerance treatment market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounts for the largest revenue share in the global market. The market dominance in this region is majorly attributed to the high prevalence of gluten intolerance treatment among people. For instance, according to recent research by “VeryWell Health” in 2022, celiac disease affects around one in every 133 persons in the United States. That equates to 1% of the overall population or around 2 million individuals. However, more than 80% of persons with celiac disease go untreated or are misdiagnosed, particularly those from low-income families. There is greater awareness of celiac disease in North America, and as a result, more people are being diagnosed with the condition. This has led to increased demand for gluten-free products and treatments.
Additionally, North America has a wide range of gluten-free products available, from gluten-free bread and pasta to snacks and beverages. This has made it easier for people with celiac disease or gluten intolerance treatment to maintain a gluten-free diet. North America has advanced healthcare infrastructure, which has led to better diagnosis and treatment of celiac disease. This has also led to the developing of new treatments and therapies for celiac disease. North America has a higher disposable income than other regions, leading to increased spending on healthcare and gluten-free products.
Based on the regions, the global gluten intolerance treatment market is segmented into:
Regional demarcation of the industry will provide information on geographic pockets regarding gluten intolerance treatment market outlook, size, share, and growth rate. This data helps businesses evaluate the expansion potential into new regional markets, understand the competitive threats across different regions, and develop localized sales and expansion strategies.
Competitive Landscape
The prominent players operating in the gluten intolerance treatment market are:
Strategic Developments
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Reasons to Buy this Report
Gluten intolerance, also known as gluten sensitivity, is a condition where the body cannot tolerate gluten, a protein found in wheat, barley, and rye. In this condition, the gluten intolerance treatment immune system responds by attacking the gluten protein, leading to inflammation in the small intestine.
North America accounts for the largest revenue share in the global gluten intolerance treatment market
The global gluten intolerance treatment market is estimated to grow at a revenue CAGR of 5.70% from 2023 to 2031
The rising prevalence of celiac disease is a prominent trend in global gluten intolerance treatment.
Rising research and development activities for developing novel products are a few opportunities in the global gluten intolerance treatment market.
Lack of dedicated management drugs and limited knowledge are the major restraining factors that can hamper the overall market growth.
Anokion SA, Precigen Inc., Topas Therapeutics GmbH, and other notable players are some of the major market players in the global gluten intolerance treatment market.
Celiac disease treatment segment accounts for the highest revenue share in the global market
Europe accounts for the second-largest gluten intolerance treatment market size during the forecast period from 2023 to 2031
*Insights on financial performance are subject to the availability of information in the public domain